EAF2 knockout mice developed lung adenocarcinoma, hepatocellular carcinoma, B-cell lymphoma and high-grade murine prostatic intraepithelial neoplasia (mPIN) [8]. Here, EAF2 is linked to B-cell non-Hodgkin lymphoma.